St. Jude builds on pact with Abbott

  • Article by: JANET MOORE , Star Tribune
  • Updated: April 23, 2012 - 4:31 PM

Bigger portfolio to be marketed to U.S. doctors, hospitals.

St. Jude Medical Inc. and Abbott have bolstered an unusual alliance that essentially joins their medical device products into one portfolio that will be marketed to U.S. doctors and hospitals.

According to an announcement Monday, the portfolio includes Abbott's heart and endovascular products, including the company's top-selling heart stent Xience, with Little Canada-based St. Jude's pacemaker and heart defibrillator portfolio, as well as other cardiac-related products.

The agreement buildings upon an existing pact the two companies reached in 2008.

Janet Moore • 612-673-7752

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close